CNMD|Conmed Corp|Price:41.520|Chg%:0.89

More Details of Conmed Corp Company

CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

Conmed Corp Info



Ticker SymbolCNMD

Company nameConmed Corp

IPO dateJul 23, 1987

CEOBeyer (Patrick J)

Number of employees3900

Security typeOrdinary Share

Fiscal year-endJul 23

Address11311 Concept Boulevard

CityLARGO

Stock exchangeNASDAQ OMX NASDAQ Basic NYSE

CountryUnited States of America

Postal code33773

Phone17272142974

Websitehttps://www.conmed.com/

Ticker SymbolCNMD

IPO dateJul 23, 1987

CEOBeyer (Patrick J)

Company Executives of Conmed Corp



Name

Name/Position

Position

Shareholding

Change

Mr. David M. Bronson

Independent Director

17.24K

+479.00%

Mr. Patrick J. (Pat) Beyer

President, Chief Executive Officer, Director

10.81K

--

Mr. Brian P. Concannon

Independent Director

10.12K

+479.00%

Ms. Barbara J. Schwarzentraub

Independent Director

5.79K

+479.00%

Mr. Peter K Shagory

Executive Vice President - Strategy and Corporate Development

3.90K

+186.00%

Ms. Hollie Foust

Executive Vice President, General Counsel and Corporate Secretary

2.89K

+2886.00%

Mr. Brent Lalomia

Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations

1.13K

+174.00%

Mr. Charles (Chuck) Farkas

Independent Director

--

Ms. Johonna Marie Pelletier

Treasurer and Vice President - Tax

--

Mr. Todd W. Garner

Chief Financial Officer, Executive Vice President - Finance

--

Name

Name/Position

Position

Shareholding

Change

Mr. David M. Bronson

Independent Director

17.24K

+479.00%

Mr. Patrick J. (Pat) Beyer

President, Chief Executive Officer, Director

10.81K

--

Mr. Brian P. Concannon

Independent Director

10.12K

+479.00%

Ms. Barbara J. Schwarzentraub

Independent Director

5.79K

+479.00%

Mr. Peter K Shagory

Executive Vice President - Strategy and Corporate Development

3.90K

+186.00%

Ms. Hollie Foust

Executive Vice President, General Counsel and Corporate Secretary

2.89K

+2886.00%

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

By BusinessUSD

Name

Revenue

Proportion

General Surgery

199.73M

59.11%

Orthopedic Surgery

138.19M

40.89%

By RegionUSD

Name

Revenue

Proportion

United States

193.98M

57.40%

Europe & Middle East & Africa

58.68M

17.37%

Asia Pacific

53.83M

15.93%

Americas (excluding the United States)

31.44M

9.30%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

General Surgery

199.73M

59.11%

Orthopedic Surgery

138.19M

40.89%

Shareholding Stats

Updated: Fri, Jan 16

Shareholders

Shareholder Types

Shareholders

Proportion

BlackRock Institutional Trust Company, N.A.

13.90%

The Vanguard Group, Inc.

11.81%

EARNEST Partners, LLC

9.04%

Fuller & Thaler Asset Management Inc.

5.60%

Westwood Management Corp. (Texas)

4.29%

Other

55.35%

Shareholders

Proportion

BlackRock Institutional Trust Company, N.A.

13.90%

The Vanguard Group, Inc.

11.81%

EARNEST Partners, LLC

9.04%

Fuller & Thaler Asset Management Inc.

5.60%

Westwood Management Corp. (Texas)

4.29%

Other

55.35%

Shareholder Types

Shareholders

Proportion

Investment Advisor

55.16%

Investment Advisor/Hedge Fund

47.14%

Hedge Fund

6.89%

Research Firm

2.89%

Pension Fund

1.93%

Bank and Trust

0.67%

Individual Investor

0.59%

Family Office

0.26%

Sovereign Wealth Fund

0.06%

Institutional Shareholding



Updated: Mon, Dec 8

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q4

638

36.30M

136.51%

+226.00

2025Q3

655

36.31M

137.32%

-1.03M

2025Q2

649

37.27M

138.33%

-832.15K

2025Q1

642

38.16M

137.89%

-4.49M

2024Q4

628

38.56M

133.23%

+1.56M

2024Q3

620

37.00M

134.64%

-1.79M

2024Q2

640

38.79M

129.72%

+1.14M

2024Q1

637

37.49M

133.32%

-3.56M

2023Q4

623

39.15M

131.18%

+747.69K

2023Q3

604

38.42M

132.14%

+127.38K

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

BlackRock Institutional Trust Company, N.A.

4.31M

13.9%

-122.30K

-2.76%

Sep 30, 2025

The Vanguard Group, Inc.

3.60M

11.63%

+59.72K

+1.69%

Sep 30, 2025

EARNEST Partners, LLC

2.80M

9.04%

-31.21K

-1.10%

Sep 30, 2025

Fuller & Thaler Asset Management Inc.

1.73M

5.6%

-5.80K

-0.33%

Sep 30, 2025

Westwood Management Corp. (Texas)

1.33M

4.29%

+92.54K

+7.48%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

1.30M

4.19%

+214.13K

+19.78%

Sep 30, 2025

State Street Investment Management (US)

1.26M

4.08%

-30.08K

-2.33%

Sep 30, 2025

Managed Account Advisors LLC

1.25M

4.03%

-137.04K

-9.90%

Sep 30, 2025

Silvercrest Asset Management Group LLC

1.07M

3.47%

+221.80K

+26.03%

Sep 30, 2025

Capital Research Global Investors

1.03M

3.33%

-643.43K

-38.39%

Sep 30, 2025

Related ETFs



Updated: Sat, Dec 6

Name

Proportion

State Street SPDR S&P Health Care Equipment ETF

1.48%

ROBO Global Healthcare Technology & Innovation ETF

1.05%

Invesco S&P SmallCap Health Care ETF

0.83%

Harbor Human Capital Factor US Small Cap ETF

0.56%

First Trust Small Cap Value AlphaDEX Fund

0.49%

VictoryShares Small Cap Free Cash Flow ETF

0.36%

WisdomTree US SmallCap Quality Dividend Growth

0.24%

First Trust Small Cap Core Alphadex Fund

0.24%

Lattice Hartford Multifactor Small Cap ETF

0.23%

Franklin US Small Cap Multifactor Index ETF

0.2%

State Street SPDR S&P Health Care Equipment ETF

Proportion1.48%

ROBO Global Healthcare Technology & Innovation ETF

Proportion1.05%

Invesco S&P SmallCap Health Care ETF

Proportion0.83%

Harbor Human Capital Factor US Small Cap ETF

Proportion0.56%

First Trust Small Cap Value AlphaDEX Fund

Proportion0.49%

VictoryShares Small Cap Free Cash Flow ETF

Proportion0.36%

WisdomTree US SmallCap Quality Dividend Growth

Proportion0.24%

First Trust Small Cap Core Alphadex Fund

Proportion0.24%

Lattice Hartford Multifactor Small Cap ETF

Proportion0.23%

Franklin US Small Cap Multifactor Index ETF

Proportion0.2%

Dividend



A total of 96.37M USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Aug 08, 2025

CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 03, 2025 going ex on Sep 15, 2025

Sep 15, 2025

Oct 03, 2025

Sep 15, 2025

May 21, 2025

CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 03, 2025 going ex on Jun 13, 2025

Jun 13, 2025

Jul 03, 2025

Jun 13, 2025

Feb 25, 2025

CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 04, 2025 going ex on Mar 14, 2025

Mar 14, 2025

Apr 04, 2025

Mar 14, 2025

Dec 10, 2024

CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 03, 2025 going ex on Dec 20, 2024

Dec 20, 2024

Jan 03, 2025

Dec 20, 2024

Aug 09, 2024

CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 04, 2024 going ex on Sep 16, 2024

Sep 16, 2024

Oct 04, 2024

Sep 16, 2024

May 22, 2024

CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2024 going ex on Jun 14, 2024

Jun 14, 2024

Jul 05, 2024

Jun 14, 2024

Feb 26, 2024

CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 05, 2024 going ex on Mar 14, 2024

Mar 15, 2024

Apr 05, 2024

Mar 14, 2024

Dec 05, 2023

CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 05, 2024 going ex on Dec 15, 2023

Dec 18, 2023

Jan 05, 2024

Dec 15, 2023

Aug 10, 2023

CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 05, 2023 going ex on Sep 14, 2023

Sep 15, 2023

Oct 05, 2023

Sep 14, 2023

May 24, 2023

CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2023 going ex on Jun 14, 2023

Jun 15, 2023

Jul 05, 2023

Jun 14, 2023

Stock Splits



Date

Ex-dividend Date

Type

Ratio

No Data

Date

Ex-dividend Date

Type

Ratio

No Data